MRFF – Clinical Trials Activity Initiative – 2024 Clinical Trials Activity Grant Opportunity
The Medical Research Future Fund (MRFF) – 2024 Clinical Trials Activity Grant Opportunity will support medical research and medical innovation projects that:
- Stream 1 (Targeted Call for Research): conduct a pilot study to assess the feasibility of a new clinical trial for one or more treatments and/or management strategies for a rare cancer, rare disease and/or unmet need.
- Stream 2 (Targeted Call for Research): conduct a clinical trial of one or more treatments and/or management-based interventions for rare cancers, rare diseases and/or unmet need.
- Stream 3 (Targeted Call for Research): conduct a clinical trial that assesses the comparative effectiveness of two or more health interventions to treat a specific clinical condition, to inform the decisions of policy makers, clinicians, and consumers regarding healthcare and to minimise the use of unnecessary, ineffective, and harmful health interventions.
- Stream 4 (Targeted Call for Research): conduct an implementation science trial to determine the best ways to implement a proven preventive health intervention, screening or diagnostic test, therapeutic agent, technology or model of care that is not in routine use in Australia.
The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care.
This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health and Aged Care.
Further information on the MRFF is available from the Department of Health and Aged Care.
